NCT03297086

Brief Summary

The purpose of this study is to evaluate possible changes of angle kappa after multifocal intraocular lens implantation. Presumable influencing factors of postoperative visual axis shift (ie. biometric parameters of the eye) are investigated to determine the degree and direction of angle kappa alterations.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2016

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 12, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 29, 2017

Completed
Last Updated

September 29, 2017

Status Verified

September 1, 2017

Enrollment Period

3 months

First QC Date

September 12, 2017

Last Update Submit

September 25, 2017

Conditions

Keywords

multifocal intraocular lens, angle kappa, presbyopia

Outcome Measures

Primary Outcomes (1)

  • Measurement of changes of angle kappa after multifocal intraocular lens implantation.

    Changes in magnitude and orientation of angle kappa (deviation between the visual and pupillary axis) are measured before and after cataract surgery with multifoocal intraocular lens implantation. During pre-and postoperative examination optical biometry is carried out using Lenstar LS 900. Optical biometer determines deviation between the visual and pupillary axis that represents angle kappa. Deviation of these axes can be defined by its magnitude and orientation. Location of the pupil centre relative to the visual axis - the reference axis - is determined by x- and y-offsets using trigonometrical analysis.

    3 months

Secondary Outcomes (2)

  • Determination of influencing effect of biometrical data on postoperative visual axis shift

    3 months

  • Determination of influencing effect of intraocular lens decentration on postoperative visual axis shift

    3 months

Study Arms (2)

Bi-Flex

ACTIVE COMPARATOR

Medicontur Bi-Flex 677MY IOL was implanted into 24 eyes of 12 patients during cataract surgery. Angle kappa, biometric data and IOL decantation were measured.

Procedure: cataract surgery

ReStor

ACTIVE COMPARATOR

and Alcon Acrysof Restor SN6AD1 IOL was implanted into 36 eyes of 18 patients during cataract surgery. Angle kappa, biometric data and IOL decantation were measured.

Procedure: cataract surgery

Interventions

cataract surgery with phacoemulsification and implantation of multifocal posterior chamber intraocular lens

Bi-FlexReStor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with age related cataract and presbyopia

You may not qualify if:

  • Patients with previous ocular surgery, trauma, active ocular disease, poorly dilated pupils, or known zonular weakness and corneal astigmatism \>1.5 diopters were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CataractPresbyopia

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRefractive Errors

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2017

First Posted

September 29, 2017

Study Start

December 1, 2015

Primary Completion

February 25, 2016

Study Completion

September 11, 2017

Last Updated

September 29, 2017

Record last verified: 2017-09